FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069592425> ?p ?o ?g. }

• W2069592425 endingPage "896" @default.
• W2069592425 startingPage "891" @default.
• W2069592425 abstract "It is important to know whether a patient with Graves' disease will get into remission or not during antithyroid drug (ATD) treatment. Thyrotropin (TSH) receptor antibodies (TRAb) cause Graves' disease. Thyroid-stimulating antibody (TSAb) and TSH-binding inhibitor immunoglobulin (TBII) have been measured as TRAb to diagnose Graves' disease and to follow Graves' patients. Smooth decreases of TSAb and TBII during ATD treatment predict the remission of Graves' hyperthyroidism. We followed serial changes of TSAb and TBII in 58 Graves' patients before, during, and after ATD treatment; TSAb was measured as a stimulator assay, using porcine thyroid cells, and TBII as a receptor assay. Patterns of TSAb and TBII changes during ATD treatment differ from one patient to another. TSAb and TBII activities decreased and disappeared in 52 (group A) but continued to be high in the other 6 (group B); 39 of the 52 group A patients achieved remission, but all of the 6 group patients with persistently positive TSAb and TBII continued to have hyperthyroidism. No differences in the initial TSAb and TBII activities were noted between the 52 group A patients and the 6 group patients. Of the 52 group A patients in whom TSAb and TBII had disappeared, 44 had smooth decreases of TSAb and TBII (group A1), and 8 had complex changes of TSAb and/or TBII (group A2); 36 of the 44 group A1 patients (82%) but only 3 of the 8 group A2 patients (37%) continued to be in remission more than 1 year after ATD discontinuation. The number of remission in group A1 was significantly larger than that in group A2. No differences in the initial TSAb and TBII activities were noted between group A1 and group A2. More than 80% of group A1 patients, who had smooth decreases of TSAb and TBII, continued to be in remission longer than 1 year. We demonstrated that smooth decreases of TSAb and TBII during ATD treatment predicted the remission of Graves' hyperthyroidism. The Graves' patients can be classified into A1, A2, and groups according to the patterns of TSAb and TBII changes during ATD treatment. Group A1 patients, who had smooth decreases of TSAb and TBII, had higher rate of remission than the others. Smooth decreases of TSAb and TBII during the early phase of ATD treatment are a reliable predictor of the remission." @default.
• W2069592425 created "2016-06-24" @default.
• W2069592425 creator A5003758324 @default.
• W2069592425 creator A5052319658 @default.
• W2069592425 creator A5054786285 @default.
• W2069592425 creator A5056006041 @default.
• W2069592425 creator A5056985046 @default.
• W2069592425 creator A5064857129 @default.
• W2069592425 date "2000-10-01" @default.
• W2069592425 modified "2023-10-11" @default.
• W2069592425 title "Remission of Graves' Hyperthyroidism Predicted by Smooth Decreases of Thyroid-Stimulating Antibody and Thyrotropin-Binding Inhibitor Immunoglobulin During Antithyroid Drug Treatment" @default.
• W2069592425 cites W1966059689 @default.
• W2069592425 cites W1987237609 @default.
• W2069592425 cites W1989530702 @default.
• W2069592425 cites W1998702718 @default.
• W2069592425 cites W2057335587 @default.
• W2069592425 cites W2057364165 @default.
• W2069592425 cites W2068872567 @default.
• W2069592425 cites W2071202245 @default.
• W2069592425 cites W2105420978 @default.
• W2069592425 doi "https://doi.org/10.1089/thy.2000.10.891" @default.
• W2069592425 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11081255" @default.
• W2069592425 hasPublicationYear "2000" @default.
• W2069592425 type Work @default.
• W2069592425 sameAs 2069592425 @default.
• W2069592425 citedByCount "52" @default.
• W2069592425 countsByYear W20695924252012 @default.
• W2069592425 countsByYear W20695924252013 @default.
• W2069592425 countsByYear W20695924252014 @default.
• W2069592425 countsByYear W20695924252016 @default.
• W2069592425 countsByYear W20695924252017 @default.
• W2069592425 countsByYear W20695924252018 @default.
• W2069592425 countsByYear W20695924252019 @default.
• W2069592425 countsByYear W20695924252020 @default.
• W2069592425 countsByYear W20695924252021 @default.
• W2069592425 countsByYear W20695924252023 @default.
• W2069592425 crossrefType "journal-article" @default.
• W2069592425 hasAuthorship W2069592425A5003758324 @default.
• W2069592425 hasAuthorship W2069592425A5052319658 @default.
• W2069592425 hasAuthorship W2069592425A5054786285 @default.
• W2069592425 hasAuthorship W2069592425A5056006041 @default.
• W2069592425 hasAuthorship W2069592425A5056985046 @default.
• W2069592425 hasAuthorship W2069592425A5064857129 @default.
• W2069592425 hasConcept C126322002 @default.
• W2069592425 hasConcept C134018914 @default.
• W2069592425 hasConcept C159654299 @default.
• W2069592425 hasConcept C203014093 @default.
• W2069592425 hasConcept C2776652619 @default.
• W2069592425 hasConcept C2777608072 @default.
• W2069592425 hasConcept C2778707442 @default.
• W2069592425 hasConcept C2778715236 @default.
• W2069592425 hasConcept C526584372 @default.
• W2069592425 hasConcept C71924100 @default.
• W2069592425 hasConceptScore W2069592425C126322002 @default.
• W2069592425 hasConceptScore W2069592425C134018914 @default.
• W2069592425 hasConceptScore W2069592425C159654299 @default.
• W2069592425 hasConceptScore W2069592425C203014093 @default.
• W2069592425 hasConceptScore W2069592425C2776652619 @default.
• W2069592425 hasConceptScore W2069592425C2777608072 @default.
• W2069592425 hasConceptScore W2069592425C2778707442 @default.
• W2069592425 hasConceptScore W2069592425C2778715236 @default.
• W2069592425 hasConceptScore W2069592425C526584372 @default.
• W2069592425 hasConceptScore W2069592425C71924100 @default.
• W2069592425 hasIssue "10" @default.
• W2069592425 hasLocation W20695924251 @default.
• W2069592425 hasLocation W20695924252 @default.
• W2069592425 hasOpenAccess W2069592425 @default.
• W2069592425 hasPrimaryLocation W20695924251 @default.
• W2069592425 hasRelatedWork W2000997832 @default.
• W2069592425 hasRelatedWork W2024738126 @default.
• W2069592425 hasRelatedWork W2068872567 @default.
• W2069592425 hasRelatedWork W2069592425 @default.
• W2069592425 hasRelatedWork W2085313965 @default.
• W2069592425 hasRelatedWork W2114765813 @default.
• W2069592425 hasRelatedWork W2130835107 @default.
• W2069592425 hasRelatedWork W4301443193 @default.
• W2069592425 hasRelatedWork W4320927433 @default.
• W2069592425 hasRelatedWork W2107910019 @default.
• W2069592425 hasVolume "10" @default.
• W2069592425 isParatext "false" @default.
• W2069592425 isRetracted "false" @default.
• W2069592425 magId "2069592425" @default.
• W2069592425 workType "article" @default.